Revenue: EUR498 million, up 7% from 2023.Gross Margin: Improved by 4.5% year-on-year.REBIT: Increased to EUR17 million.Net Income: EUR9.3 million, an EUR18 mil
Mar 20, 2025 / 01:30PM GMTThomas Pevenage - Ion Beam Applications SA - Head of Investor Relations Hello and welcome to IBA's full year 2024 results conference c
Ion Beam Applications SA (OTCPK:IOBCF) Q2 2024 Results Conference Call August 29, 2024 9:00 AM ETCompany ParticipantsOlivier Legrain - CEOHenri de Romrée -...
Ion Beam Applications press release (IOBCF): FY positive Group REBIT of €6.4 million (FY22 €11.1 million).
Total Group net loss of €9.1 million (2022: €6.1 million profit).
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Proton Therapy Market...
The global radiotherapy market is experiencing growth because of various factors, such as the rise in cancer, advancements in radiotherapy machinery, and...
/PRNewswire/ -- The latest report on the image-guided therapy system market estimates to register an incremental growth of USD 1,594.18 million between...
In 2020, the market was worth USD 6.15 billion and, with a CAGR of 5.71%, is expected to reach a market value of USD 10.71 billion by 2030 according to...
The demand for Surgical Robotic Systems is witnessing a huge surge due to increasing surgical procedures which can be attributed to various factors such as...